Analyst Ratings for Hillstream BioPharma (HILS)

HILS Rating Summary

  |   Expand Research on HILS
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 0 / 10
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
7/17/2023 Dawson James Jason Kolbert Downgrade Neutral
(Buy)		 N/A
(N/A)		 0.38
(0.23)		 -39.47% Details